ARCHIVES

Rituximab Prolonged Survival Of CLL In Phase III Study

This article is from The Cancer Letter archive.

Vol. 33 No. 9 | September 24, 2010

Download PDF Visit The Full Archive

Related Articles

Tom Harkin Is New Chairman f Senate Labor-HS-Education Subcommittee

January 13, 1989

In Brief: Richard Fisher Named Fox Chase President and CEO

August 2, 2013

NCI Should Examine Alternative Therapies TA Report Says

September 28, 1990

FDA Deputy Commissioner Gottlieb To Return To AEI.

December 15, 2006

ODAC Prefers Three-Hour Taxol Infusion. Says Data Dosage Still Uncertain

October 1, 1993

Preoperative Drug Combo Benefits HER-2 Breast Cancer

April 29, 2005